A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
06
05
2022
accepted:
14
11
2022
entrez:
15
12
2022
pubmed:
16
12
2022
medline:
20
12
2022
Statut:
epublish
Résumé
Smoking rates among patients with rheumatoid arthritis (RA) exceed those in the general population. This study identified smoking cessation strategies used in patients with RA and synthesized data on their effects. We conducted a systematic review of studies that reported effects of interventions for smoking cessation in patients with RA. We searched 5 electronic databases until March 2022. Screening, quality appraisal, and data collection were done independently by 2 reviewers. We included 18 studies reporting interventions for patients or providers: 14 evaluated strategies for patients (5 education on cardiovascular risk factors including smoking, 3 educational interventions on smoking cessation alone, 3 education with nicotine replacement and counseling, and 1 study each: education with nicotine replacement, counseling sessions alone, and a social marketing campaign). Smoking cessation rates ranged from 4% (95% CI: 2%-6%, 24 to 48 weeks) for cardiovascular risk education to 43% (95% CI: 21%-67%, 104 weeks) for counseling sessions alone. The pooled cessation rate for all interventions was 22% (95% CI: 8%-41%, 4 weeks to 104 weeks; 9 studies). Four interventions trained providers to ascertain smoking status and provide referrals for smoking cessation. The pooled rates of referrals to quit services increased from 5% in pre-implementation populations to 70% in post-implementation populations. Studies varied in patient characteristics, the interventions used, and their implementation structure. Only 3 studies were controlled clinical trials. Additional controlled studies are needed to determine best practices for smoking cessation for patients with RA.
Identifiants
pubmed: 36520847
doi: 10.1371/journal.pone.0279065
pii: PONE-D-22-13191
pmc: PMC9754184
doi:
Substances chimiques
Nicotine
6M3C89ZY6R
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0279065Subventions
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA056452
Pays : United States
Informations de copyright
Copyright: © 2022 Lopez-Olivo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Arthritis Rheum. 1980 Feb;23(2):137-45
pubmed: 7362664
Cochrane Database Syst Rev. 2019 Sep 02;9:CD012958
pubmed: 31476270
Joint Bone Spine. 2019 Mar;86(2):275
pubmed: 30268815
BMJ. 2000 Aug 5;321(7257):323-9
pubmed: 10926586
Ann Rheum Dis. 2001 Mar;60(3):223-7
pubmed: 11171682
Respir Care. 2008 Sep;53(9):1217-22
pubmed: 18807274
Trials. 2017 Nov 28;18(1):570
pubmed: 29183347
Musculoskeletal Care. 2018 Mar;16(1):74-81
pubmed: 28681572
Am J Med. 1999 Mar;106(3):311-4
pubmed: 10190380
Addiction. 2017 Dec;112(12):2227-2236
pubmed: 28834608
Ann Rheum Dis. 2002 Jan;61(1):66-9
pubmed: 11779763
Rheumatology (Oxford). 2015 Aug;54(8):1528-30
pubmed: 26018439
Arthritis Res Ther. 2014 Mar 05;16(2):R61
pubmed: 24594022
Rheumatol Int. 2014 Jan;34(1):93-9
pubmed: 24005567
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
J Rheumatol. 1982 Sep-Oct;9(5):789-93
pubmed: 7175852
MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1205-1211
pubmed: 27832052
Arthritis Care Res (Hoboken). 2020 Mar;72(3):369-377
pubmed: 30768768
Cochrane Database Syst Rev. 2018 May 31;5:CD000146
pubmed: 29852054
Ann Rheum Dis. 2010 Jan;69(1):70-81
pubmed: 19174392
Rheumatology (Oxford). 2013 Jan;52(1):81-90
pubmed: 22942402
Open Rheumatol J. 2012;6:303-9
pubmed: 23115602
Arthritis Res Ther. 2008;10(2):R30
pubmed: 18325087
Arthritis Care Res (Hoboken). 2017 Jan;69(1):28-37
pubmed: 27333261
Arthritis Care Res (Hoboken). 2013 Jun;65(6):870-8
pubmed: 23281173
Res Synth Methods. 2021 Jan;12(1):55-61
pubmed: 32336025
BMJ Open. 2021 Jan 26;11(1):e038137
pubmed: 33500279
MMWR Surveill Summ. 2010 Apr 16;59(3):1-75
pubmed: 20395937
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Arthritis Rheum. 2010 Jun;62(6):1576-82
pubmed: 20191579
JAMA. 2021 Jan 19;325(3):265-279
pubmed: 33464343
Eur Respir J. 2008 Oct;32(4):844-53
pubmed: 18827152
Rheumatol Rehabil. 1977 Nov;16(4):257-9
pubmed: 414343
Arthritis Care Res (Hoboken). 2018 Jan;70(1):19-29
pubmed: 28464477
Int J Qual Stud Health Well-being. 2020 Dec;15(1):1725997
pubmed: 32046611
Arthritis Care Res (Hoboken). 2022 Sep;74(9):1421-1429
pubmed: 33825349
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
RMD Open. 2017 Sep 26;3(2):e000506
pubmed: 29018566
J Rheumatol. 2016 Apr;43(4):691-8
pubmed: 26879360
Rheumatology (Oxford). 2016 Nov;55(11):1969-1977
pubmed: 27477806
Musculoskeletal Care. 2018 Mar;16(1):139-146
pubmed: 29235264
Tob Control. 2018 Jan;27(1):58-64
pubmed: 28138063
Cochrane Database Syst Rev. 2013 May 31;(5):CD000165
pubmed: 23728631
BMJ Open. 2021 Mar 24;11(3):e043612
pubmed: 33762234
Ann Rheum Dis. 2012 Dec;71(12):1942-9
pubmed: 22532638